Delivery Order SPE2DR25D2104-SPE2DR26F3SJD
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $4,859.45 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count packaging), with an ultimate completion date of December 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition on December 22, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a $7,137.99 delivery order to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (90-count units) with a firm fixed price contract type. The award was made on December 18, 2025, with an ultimate completion date of December 19, 2025, and represents a non-competitive, non-set-aside procurement. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $2,337.94 delivery order to AmerisourceBergen Drug Corp for 30 tablets of Kerendia 10 mg on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price contract, which carries no set-aside designation, represents a competitively awarded delivery order under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. The pharmaceutical product will be delivered to the company's corporate office location in...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,123.04 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (90-count supply) on December 12, 2025, with an ultimate completion date of December 15, 2025. This firm fixed-price delivery order is non-set-aside and represents a child contract under AmerisourceBergen's broader indefinite delivery vehicle with the DLA. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $4,472.70 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) on December 29, 2025, with an ultimate completion date of December 30, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award to this pharmaceutical distributor. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,110.21 on December 12, 2025, for the supply of Kerendia 10 mg tablets (30-count units). This competitively awarded, firm fixed-price contract represents a non-set-aside procurement supporting federal medical supply needs. The ultimate completion date is December 15, 2025, with performance occurring at the contractor's corporate office in Conshohocken, Pennsylvania. This delivery order is executed under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for $38,149.93 to supply Kerendia 10 mg tablets (30-count units) with a firm fixed price structure. This competitive award, issued on September 11, 2025, with an ultimate completion date of September 12, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The contract does not utilize a set-aside designation and will be performed at the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Kerendia 20 mg tablets (30-count) with a ceiling value of $1,038.89. This competitively awarded, firm fixed-price delivery order is not set-aside and is scheduled for completion by December 11, 2025. AmerisourceBergen will fulfill this requirement from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a...
- The Defense Logistics Agency awarded a delivery order valued at $5,658.96 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count units) on December 2, 2025, with completion scheduled for December 3, 2025. The contract employs firm fixed pricing with no set-aside designation, indicating competitive award selection. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $2,526.66 to AmerisourceBergen Drug Corp for Kerendia 10 mg tablets (30-count) on November 25, 2025, with completion scheduled for November 26, 2025. This firm fixed-price, competitively awarded delivery order represents a continuation of pharmaceutical supply under AmerisourceBergen's existing indefinite delivery contract with DLA Troop Support Medical. The place of performance is AmerisourceBergen's corporate office in...
- SPE2DR25D2104Indefinite Delivery Contract
- SPE2DR25D2104-SPE2DR26F3SJDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,160.25 to AmerisourceBergen Drug Corp for the supply of Kerendia 10 mg tablets (30-count packaging) under a firm fixed price contract. The order, issued on December 29, 2025 with an ultimate completion date of December 30, 2025, represents a competitively awarded, non-set-aside procurement executed through AmerisourceBergen's existing pharmaceutical supply agreement with the federal government. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a $999,999,999.00 prime vendor agreement running through December 2026 that authorizes the company to supply a comprehensive range of pharmaceuticals and medical supplies to support military healthcare programs globally. As a major pharmaceutical distributor, AmerisourceBergen serves critical federal medical procurement needs across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's federal contract portfolio demonstrates extensive experience fulfilling federal pharmaceutical requirements across multiple therapeutic domains, including specialty medications, vaccines, and medical devices, positioning it as a key vendor within the military medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.2k | 12/28/25 |